0.4650
+0.0150
+(3.33%)
At close: January 17 at 3:45:59 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-15,636.1180
-14,696.2530
-11,867.9050
-10,923.6340
-6,479.9609
Investing Cash Flow
48.0100
206.0110
-1,748.7940
-1,139.3220
5,676.3504
Financing Cash Flow
7,066.7110
234.4730
40,284.2020
7,911.3060
7,716.3979
End Cash Position
9,584.4400
13,980.1760
28,439.0480
3,723.1320
7,861.8542
Capital Expenditure
-377.0590
-474.5030
-1,991.3690
-1,671.2300
--
Issuance of Capital Stock
7,211.2570
--
38,136.7600
--
7,378.1086
Repayment of Debt
-144.5640
-284.8430
-227.0870
-161.4650
-110.6426
Free Cash Flow
-16,013.1770
-15,170.7560
-13,859.2740
-12,594.8640
-6,479.9609
12/31/2020 - 8/8/1996
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PROF Profound Medical Corp.
7.35
-1.08%
SECT-B.ST Sectra AB (publ)
249.95
-1.38%
PRN.TO Profound Medical Corp.
10.55
-1.40%
CNVI.V Conavi Medical Corp.
0.8000
+3.90%
TELA TELA Bio, Inc.
2.6900
+1.13%
VPT.V Ventripoint Diagnostics Ltd.
0.1000
0.00%
FNA Paragon 28, Inc.
10.88
+2.06%
IART Integra LifeSciences Holdings Corporation
24.10
+3.70%
NMTC NeuroOne Medical Technologies Corporation
1.0500
+0.96%
DCTH Delcath Systems, Inc.
14.31
+4.68%